SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 93 filers reported holding SAGE THERAPEUTICS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $2,894,000 | -67.4% | 50,945 | -57.0% | 1.16% | -63.9% |
| Q1 2021 | $8,870,000 | -59.9% | 118,500 | -53.7% | 3.20% | -46.9% |
| Q4 2020 | $22,129,000 | +60.9% | 255,800 | +13.7% | 6.02% | +61.2% |
| Q3 2020 | $13,752,000 | +867.8% | 225,000 | +1025.0% | 3.74% | +1008.3% |
| Q1 2017 | $1,421,000 | +44.4% | 20,000 | +18.5% | 0.34% | -28.5% |
| Q4 2015 | $984,000 | +144.8% | 16,877 | +111.0% | 0.47% | +38.9% |
| Q1 2015 | $402,000 | – | 8,000 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,966,688 | $120,204,000 | 10.81% |
| Integral Health Asset Management, LLC | 230,000 | $14,058,000 | 4.30% |
| Asymmetry Capital Management, L.P. | 102,462 | $6,262,000 | 4.02% |
| ACUTA CAPITAL PARTNERS, LLC | 225,000 | $13,752,000 | 3.74% |
| DAFNA Capital Management LLC | 158,306 | $9,676,000 | 3.14% |
| Bain Capital Life Sciences Investors, LLC | 499,100 | $30,505,000 | 2.84% |
| Boxer Capital, LLC | 1,094,000 | $66,865,000 | 2.31% |
| Palo Alto Investors LP | 590,200 | $36,073,000 | 1.98% |
| Logos Global Management LP | 250,000 | $15,280,000 | 1.96% |
| Bellevue Group AG | 1,579,504 | $96,539,000 | 1.33% |